Page last updated: 2024-10-28

hexamethonium and Gastric Diseases

hexamethonium has been researched along with Gastric Diseases in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ETTMAN, IK1
BOUCHILLON, CD1
HALFORD, HH1

Other Studies

1 other study available for hexamethonium and Gastric Diseases

ArticleYear
Gastrointestinal roentgen findings due to untoward effects of hexamethonium.
    Radiology, 1957, Volume: 68, Issue:5

    Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Intestinal Obstruction; Stomach; Stoma

1957